Novel Emerging Investigational Treatment Strategies for Patients With Myelofibrosis
- Author
- Jacqueline S Garcia MD
- Published
- Thu 30 Nov 2023
- Episode Link
- https://oncologypodcast.simplecast.com/episodes/novel-emerging-investigational-treatment-strategies-for-patients-with-myelofibrosis-j7tCfHSO
In this episode, Jacqueline S. Garcia, MD, discusses novel agents and strategies in clinical trial development for treating patients with myelofibrosis, including:
- Navitoclax (BCL-XL/BCL-2 inhibitor)
- Pelabresib (BET inhibitor)
- Imetelstat (telomerase inhibitor)
- Luspatercept (erythroid maturation agent)
- Additional strategies
Presenter:
Jacqueline S. Garcia, MD
Assistant Professor of Medicine
Harvard Medical School
Dana-Farber Cancer Institute
Boston, Massachusetts
Link to the full program here. https://bit.ly/47z8WCV
